3 Months to Complete COVID Vax Trial? AMA Chief Doubts It
‘It will be a challenge to make that happen’
‘It will be a challenge to make that happen’
A recent review has found that high-dose upadacitinib is among the most effective therapies for addressing multiple outcomes in moderate-to-severe atopic dermatitis (AD), but is…
Allergist Zahida Maskatia, MD, shares how the guidelines will change practice
Topline data show where sodium phenylbutyrate and taurursodiol fell short
Seven outbreaks have occurred already in the first quarter of 2024
Atherogenic particle appeared to be a risk factor regardless of age, sex, race, diabetes status
Video education may help more patients with prostate and other cancers get much-needed genetic counseling and testing, according to study in . The rates of…
The symptoms of hypercortisolism may be caused by endogenous Cushing syndrome or a number of other non-neoplastic conditions. Thus, recognizing the…
Fourfold seroconversion rate of 100% in all active vaccine groups
Independent reviewers reject causal links to infertility, myocardial infarction, stroke
Nine people hospitalized across nine states after receiving the injections